Silicone Axillary Lymphadenopathy Associated With Rupture of Fourth-Generation Cohesive Silicone Breast Implants Following Breast Augmentation.
Abstract
[BACKGROUND] Silicone implant rupture is a common complication of breast augmentation, with silicone axillary lymphadenopathy (SAL) a recognized sequela.
[OBJECTIVES] To evaluate SAL associated with surgically confirmed rupture of fourth-generation cohesive silicone breast implants and correlate imaging with operative findings.
[METHODS] A retrospective review included 260 consecutive patients undergoing surgery for removal of one or more ruptured cohesive silicone implants identified by non-contrast breast/axillary MRI and ultrasound. The implant-side was the unit of analysis, with bilateral ruptures counted separately. Implant characteristics, including manufacturer, volume, rupture type, and implant age at explantation, were correlated with ipsilateral axillary findings. All patients had primary augmentation with Allergan plc (Irvine, CA) or Mentor Worldwide LLC (Irvine, CA) fourth-generation cohesive implants and available implant records. Operative findings confirmed implant type, size, rupture presence, and rupture characteristics.
[RESULTS] Among 260 patients, 299 ruptured implant-sides were identified, with imaging findings corroborated surgically. Intracapsular rupture accounted for 81.6% of ruptured implant-sides with 18.4% extracapsular ruptures. SAL occurred with both intracapsular and extracapsular rupture types but was more commonly seen with extracapsular rupture. Increasing implant age at explantation showed a strong independent association with SAL, while extracapsular rupture demonstrated a modest independent association. No significant differences in SAL were observed by implant manufacturers.
[CONCLUSIONS] SAL was frequently observed in patients undergoing surgical management of ruptured smooth, fourth-generation cohesive silicone implants. Increasing implant age at explantation was independently associated with SAL, while extracapsular rupture showed a modest independent association. These findings strongly influence patient counseling and surgical evaluation of aging fourth-generation silicone implants. Further study of newer fifth-generation highly cohesive implants is warranted.
[OBJECTIVES] To evaluate SAL associated with surgically confirmed rupture of fourth-generation cohesive silicone breast implants and correlate imaging with operative findings.
[METHODS] A retrospective review included 260 consecutive patients undergoing surgery for removal of one or more ruptured cohesive silicone implants identified by non-contrast breast/axillary MRI and ultrasound. The implant-side was the unit of analysis, with bilateral ruptures counted separately. Implant characteristics, including manufacturer, volume, rupture type, and implant age at explantation, were correlated with ipsilateral axillary findings. All patients had primary augmentation with Allergan plc (Irvine, CA) or Mentor Worldwide LLC (Irvine, CA) fourth-generation cohesive implants and available implant records. Operative findings confirmed implant type, size, rupture presence, and rupture characteristics.
[RESULTS] Among 260 patients, 299 ruptured implant-sides were identified, with imaging findings corroborated surgically. Intracapsular rupture accounted for 81.6% of ruptured implant-sides with 18.4% extracapsular ruptures. SAL occurred with both intracapsular and extracapsular rupture types but was more commonly seen with extracapsular rupture. Increasing implant age at explantation showed a strong independent association with SAL, while extracapsular rupture demonstrated a modest independent association. No significant differences in SAL were observed by implant manufacturers.
[CONCLUSIONS] SAL was frequently observed in patients undergoing surgical management of ruptured smooth, fourth-generation cohesive silicone implants. Increasing implant age at explantation was independently associated with SAL, while extracapsular rupture showed a modest independent association. These findings strongly influence patient counseling and surgical evaluation of aging fourth-generation silicone implants. Further study of newer fifth-generation highly cohesive implants is warranted.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | sal
|
지방흡입 | dict | 7 | |
| 해부 | breast
|
유방 | dict | 5 | |
| 시술 | breast augmentation
|
유방성형술 | dict | 2 | |
| 해부 | implant-side
|
scispacy | 1 | ||
| 해부 | smooth
|
scispacy | 1 | ||
| 합병증 | extracapsular rupture
|
scispacy | 1 | ||
| 합병증 | implant rupture
|
보형물 파열 | dict | 1 | |
| 재료 | silicone implant
|
실리콘 보형물 | dict | 1 | |
| 약물 | silicone
|
C0037114
silicones
|
scispacy | 1 | |
| 약물 | [BACKGROUND] Silicone implant rupture is
|
scispacy | 1 | ||
| 약물 | [OBJECTIVES]
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS] SAL
|
scispacy | 1 | ||
| 질환 | Lymphadenopathy
|
C0497156
Lymphadenopathy
|
scispacy | 1 | |
| 질환 | Rupture of Fourth-Generation Cohesive Silicone Breast
|
scispacy | 1 | ||
| 질환 | Silicone implant rupture
|
scispacy | 1 | ||
| 질환 | rupture
|
C3203359
Rupture
|
scispacy | 1 | |
| 질환 | silicone breast
|
scispacy | 1 | ||
| 질환 | ruptured cohesive silicone
|
scispacy | 1 | ||
| 질환 | Intracapsular rupture
|
scispacy | 1 | ||
| 질환 | extracapsular rupture
|
scispacy | 1 | ||
| 질환 | Breast Implants
|
scispacy | 1 | ||
| 기타 | Silicone Axillary Lymphadenopathy
|
scispacy | 1 | ||
| 기타 | axillary lymphadenopathy
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | bilateral ruptures
|
scispacy | 1 | ||
| 기타 | ipsilateral axillary
|
scispacy | 1 | ||
| 기타 | Allergan plc
|
scispacy | 1 | ||
| 기타 | Intracapsular
|
scispacy | 1 | ||
| 기타 | extracapsular
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Clinical outcomes of synthetic absorbable mesh use in breast surgery: First case series in reconstruction and aesthetic mastopexy.
- Implant-based versus autologous mastopexy after massive weight loss: Complications and patient satisfaction.